New Food GEA to Develop World's First Pilot Plant for Krill Protein Production
GEA has been awarded an EPC (engineering, procurement and construction) contract by the biotechnology company Aker BioMarine to establish the world’s first pilot plant for hydrolyzing krill protein. The facility is expected to be operational by 2022.
Düsseldorf/Germany – Aker BioMarine is a biotechnology company based in Norway that fishes for Antarctic krill – tiny shrimp-like crustaceans – and uses them to develop ingredients for functional foods, aquaculture and animal feed. Slated to come online in late 2022, the new pilot plant will produce a highly concentrated protein isolate destined for food and beverages. The pilot plant is the next step in commercializing krill human protein powder. It will expand the current small-scale process to a scalable, industrial production level with a capacity of 120 tons per year.
The partners signed the EPC contract, valued in the double-digit million-dollar range, in July 2021.
"Thanks to innovative companies such as Aker BioMarine, the topic of ‘New Food’ is currently developing into an increasingly important future market, which is also of strategic importance for GEA. This is unlocking entirely new sources of human nutrition and health. We are pleased to join Aker BioMarine on their journey into researching and commercializing krill protein - and to do so in a way that is absolutely climate and environmentally friendly," says Ilija Aprcovic, CEO of the Liquid & Powder Technologies Division of GEA Group.
Aker BioMarine intends to decarbonize both its krill fisheries and production.